share_log

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veru Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: VERU)

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veru Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: VERU)

股东提醒:格罗斯律师事务所将集体诉讼和首席原告的最后期限通知Veru Inc.的股东-(纳斯达克股票代码:VERU)
PR Newswire ·  2023/02/01 05:56

NEW YORK, Feb. 1, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Veru Inc..

纽约2023年2月1日 /PRNewswire/ — Gross Law Firm 向以下股东发出以下通知 Veru Inc.

Shareholders who purchased shares of VERU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

鼓励在上市集体诉讼期内购买VERU股票的股东就可能的首席原告任命与公司联系。无需被任命为首席原告即可参与任何追偿。

CONTACT US HERE:

在这里联系我们:

CLASS PERIOD: This lawsuit is on behalf of all investors who purchased or otherwise acquired Veru Inc. common stock between May 11, 2022 and November 9, 2022, inclusive.

上课时间: 该诉讼是代表所有在两者之间购买或以其他方式收购Veru Inc.普通股的投资者提起的 2022年5月11日2022年11月9日,包括。

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: 1) the Company had withheld material adverse facts about the data from the sabizabulin Phase 3 trial and the Company's interactions with the United States Food and Drug Administration; 2) defendants misled Veru's shareholders to believe that the data from the sabizabulin Phase 3 trial was sufficient to support Emergency Use Authorization ("EUA") and even the submission of a New Drug Application without any further studies; and 3) the Company's filings concealed the true risks faced by Veru in gaining approval for its EUA request.

指控: 投诉称,在集体诉讼期间,被告发布了重大虚假和/或误导性陈述和/或未能披露:1) 公司隐瞒了有关sabizabulin第三阶段试验数据以及公司与美国食品药品监督管理局互动的重大不利事实;2) 被告误导了Veru的股东,使他们认为sabizabulin第三阶段试验的数据足以支持紧急使用授权(“EUA”)甚至没有进一步就提交了新药申请研究;以及 3) 该公司的文件掩盖了Veru在获得EUA申请批准时面临的真正风险。

DEADLINE: February 6, 2023 Shareholders should not delay in registering for this class action. Register your information here:

截止日期: 2023年2月6日 股东不应拖延登记参加本次集体诉讼。在这里注册您的信息:

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of VERU during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 6, 2023. There is no cost or obligation to you to participate in this case.

股东的下一步行动: 一旦您注册为在上述时间范围内购买了VERU股票的股东,您将注册投资组合监控软件,在案件的整个生命周期内为您提供最新状态。寻求成为首席原告的最后期限是 2023年2月6日。您无需支付任何费用或义务即可参与此案件。

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

为什么是格罗斯律师事务所? Gross Law Firm是全国认可的集体诉讼律师事务所,我们的使命是保护所有因欺骗、欺诈和非法商业行为而遭受损失的投资者的权利。Gross Law Firm致力于确保公司遵守负责任的商业惯例并树立良好的企业公民意识。该公司代表投资者寻求追偿,这些投资者在虚假和/或误导性陈述或遗漏重要信息导致公司股票人为通货膨胀时蒙受损失。律师广告。先前的结果并不能保证类似的结果。

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

联系人:
格罗斯律师事务所
西 38 街 15 号,12 楼
纽约,纽约,10018
电子邮件:[电子邮件保护]
电话:(646) 453-8903

SOURCE The Gross Law Firm

来源 Gross Law Firm

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发